Management of disturbed calcium metabolism in uraemic patients: 2. Indications for parathyroidectomy

Nephrology Dialysis Transplantation

Volumn 15, Issue SUPPL. 5, 2000, Pages 25-29

  Schomig, M ^a   Ritz, E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; ALUMINUM; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; DEFEROXAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; MICROSATELLITE DNA; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PHOSPHATE; PROTEIN P16; PROTEIN P53; VITAMIN D; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE TURNOVER; CALCIUM METABOLISM; CALCIUM TRANSPORT; CLINICAL PROTOCOL; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; HYPOCALCEMIA; NONHUMAN; OSTEOMALACIA; PARATHYROID CELL; PARATHYROID HYPERPLASIA; PARATHYROIDECTOMY; PATHOPHYSIOLOGY; POSTOPERATIVE CARE; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT INDICATION; UREMIA;

EID: 0033787070     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.suppl_5.25     Document Type: Article

References (65)

1. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia
2. Genetic abnormalities in parathyroid nodules of uremic patients
3. Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism
4. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients
5. Mechanism of parathyroid tumorigenesis in uraemia
6. 2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia
7. Parathyroid autografts morphology and function: Six years experience with parathyroid autotransplantation in uremic patients
8. Secondary hyperparathyroidism: Pathophysiology, histopathology, and medical and surgical management
9. Morphologic and functional studies to prevent graft-dependent recurrence in renal osteodystrophy
10. Parathyroidectomy and autotransplantation in renal hyperparathyroidism. II. Morphologic and functional studies in transplant-dependent recurrence
11. Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients
12. Results of subtotal parathyroidectomy in hemodialysis patients
13. Recurrence of autonomous hyperparathyroidism in dialysis patients
14. Secondary hyperparathyroidism complicated by parathyromatosis
15. Parathyroid carcinoma in patients with chronic renal failure on maintenance hemodialysis
16. Lung metastasis from parathyroid carcinoma causing recurrent renal hyperparathyroidism in a hemodialysis patient: Report of a case
17. Parathyroid carcinoma with multiple lung metastases
18. Loss of calcium responsiveness in cultured bovine parathyroid cells is associated with decreased calcium receptor expression
19. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism
20. Effect of 22-oxacalcitriol on calcium metabolism in rats with severe hyperparathyroidism
21. Proliferation of parathyroid cells negatively correlates with expression of parathyroid hormone-related protein in secondary parathyroid hyperplasia
22. The pathogenesis of parathyroid gland hyperplasia in chronic renal failure
23. Apoptosis in parathyroid hyperplasia of patients with primary or secondary uremic hyperparathyroidism
24. Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol
25. Regression of parathyroid hyperplasia by calcitriol pulse therapy in patients on long-term dialysis
26. Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD
27. Which is the preferred treatment of advanced hyperparathyroidism in a renal patient? II. Early parathyroidectomy should be considered as the first choice
28. Hypercalcemic hyperparathyroidism following renal transplantation: Differential diagnosis, management, and implications for cell population control in the parathyroid gland
29. Reversibility of experimental secondary hyperparathyroidism
30. Identification of risk factors on secondary hyperparathyroidism undergoing long-term haemodialysis with vitamin D3
31. Combined report on regular dialysis and transplantation in Europe, XX, 1989
32. Report on management of renal failure in Europe, XXV, 1994
33. Calciphylaxis in chronic renal failure
34. Parathyroidectomy in secondary (renal) hyperparathyroidism who, when, how?
35. Parathyroid gland size is critical for longterm prognosis of calcitriol pulse therapy in chronic dialysis patients
36. Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism
37. Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism?
38. Three-dimensional analysis of the spine in autopsy cases with renal osteodystrophy
39. Hyperphosphataemia a silent killer of patients with renal failure?
40. Parathyroidectomy after renal transplantation: A retrospective analysis of long-term outcome
41. Risk factors for renal osteodystrophy: A multivariant analysis
42. Surgical treatment of renal hyperparathyroidism
43. Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism
44. Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism
45. Total parathyroidectomy and renal function in patients with chronic renal failure
46. Percutaneous autotransplantation of parathyroid tissue into the forearm muscles
47. Long-term results of subcutaneous parathyroid grafts in uremic patients
48. Autotransplantation of parathyroid glands into subcutaneous forearm tissue for renal hyperparathyroidism
49. Results of heterotopic parathyroid autotransplantation: A 13-year experience
50. New technique of parathyroidectomy to prevent parathyromatosis and hypoparathyroidism
51. Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients
52. Elective total parathyroidectomy without autotransplant in end-stage renal disease
53. How complete is a total parathyroidectomy in uraemia?
54. Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure
55. Ultrasound-guided percutaneous fine-needle ethanol injection into parathyroid glands in secondary hyperparathyroidism
56. Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism
57. Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients
58. Medical and surgical aspects of parathyroidectomy
59. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients
60. Accelerated progression of chronic renal insufficiency after parathyroidectomy
61. Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: Further evidence implicating calcium homeostasis in blood pressure regulation
62. Changes in plasma renin and aldosterone after parathyroidectomy in patients with hyperparathyroidism
63. Effects of parathyroidectomy on induced renal failure in dogs